首页> 外文会议>NSTI Nanotechnology Conference and Trade Show >Formation of Nanoparticles of a Hydrophilic Drug using Supercritical CO_2 and Microencapsulation for Sustained Release
【24h】

Formation of Nanoparticles of a Hydrophilic Drug using Supercritical CO_2 and Microencapsulation for Sustained Release

机译:使用超临界CO_2形成亲水药物的纳米颗粒和微胶囊持续释放

获取原文

摘要

The objective of this work was to develop sustained release formulation for hydrophilic drugs with minimal burst effects. For this purpose, nanoparticles of a hydrophilic drug were produced using supercritical CO_2, which were then encapsulated into polymer microparticles using an anhydrous method, followed by studying their sustained in-vitro drug release. A hydrophilic drug, dexamethasone phosphate, was dissolved in methanol and injected in supercritical CO_2 with ultrasonic field for enhanced molecular mixing (SAS-EM technique). Supercritical CO_2 rapidly extracts methanol leading to instantaneous precipitation of drug nanoparticles of 150 nm. These nanoparticles, on encapsulation in poly(lactide-co-glycolide) polymer using anhydrous s/o/o/o technique, resulted in the well-dispersed encapsulation of drug nanoparticles in polymer microspheres of ~70 μm. Their in-vitro drug release showed sustained release of-dexamethasone phosphate over a period of 700 hours with almost no initial burst release.
机译:这项工作的目的是为亲水药物进行持续释放配方,具有最小的突发效应。为此目的,使用超临界CO_2制备亲水药物的纳米颗粒,然后使用无水法将其包封成聚合物微粒,然后研究其持续的体外药物释放。亲水性药物,磷酸盐,溶解在甲醇中,并用超声电场注射超临界CO_2,以增强分子混合(SAS-EM技术)。超临界CO_2快速提取甲醇,导致瞬时沉淀的药物纳米粒子为150nm。这些纳米颗粒在使用无水S / O / O / O / O技术的聚(丙交酯 - 共乙酰胺)聚合物中的封装中的封装,导致在〜70μm的聚合物微球中的药物纳米颗粒的井分散封装。它们的体外药物释放在700小时的时间内显示出持续释放的 - 地塞米松磷酸盐,几乎没有初始爆发释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号